Streetlab and Iris Pharma: a Partnership Aimed at Integrating Quality of Life in the Clinical Assessment of New Products for Use by the Visually Impaired
Streetlab, a company which works to improve independence, mobility and quality of life for the visually impaired, has announced a strategic partnership agreement with Iris Pharma, an ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services. This partnership forms the basis of a new service offer for the pharmaceutical industry, with the integration of a methodological approach which is focused on human factors in the assessment of new drugs, medical devices or technologies for the use of partially sighted people.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170201005576/en/
In Paris, within the Institut de la Vision, Streetlab has several innovative testing platforms which provide real solutions in assessing the mobility, vision and object apprehension strategy among the visually impaired using motion capture systems under controlled and reproducible environmental conditions. As part of this partnership, Iris Pharma will contribute its almost 30 years experience in ophthalmology as well as its unique expertise and knowledge of all stages of research and development, especially when establishing and managing clinical trials." We are delighted with this partnership, which will provide us with some synergy in the control of clinical trials. The post-drug or post-surgical therapeutic benefit is now objectively measurable using an innovative assessment of the impact on performing everyday tasks " explains Mr. Emmanuel Gutman, Chief Executive Officer of Streetlab.
While demographic changes in industrialized countries have led to a significant increase in the number of people with visual impairments, the acceleration of scientific progress in ophthalmology heralds significant future therapeutic innovations." By combining our respective fields of expertise, together we can provide healthcare firms with assessment criteria for calibrated, innovative clinical trials which are adapted as closely as possible to the specific needs of visually impaired patients, thus meeting innovation challenges as successfully as possible " clarifies Mr. Yann Quentric, President of Iris Pharma.
About Streetlab
Created by the Institut de la Vision and
headed by the Professor José-Alain Sahel, the purpose of Streetlab is to
assess products and services in order to improve independence, mobility
and the quality of life of visually impaired people. Thanks to its close
collaboration with the Quinze-Vingts Hospital, the company enjoys
first-rate medical and scientific expertise.
http://www.streetlab-vision.com
About Iris Pharma
A leading CRO dedicated to ophthalmology,
Iris Pharma helps clients around the world navigate every stage of the
drug and device development process – including in vivo screening, proof
of concept, ocular efficacy, GLP preclinical studies, bioanalysis,
clinical trials, and marketing surveys. This CRO has expertise in all
ophthalmic indications, and supports clients ranging from small
start-ups to large pharmaceutical companies in moving forward products
that directly or indirectly affect eye health.
http://www.iris-pharma.com
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170201005576/en/
Contact information
Iris Pharma
Yann Quentric
info@iris-pharma.com
or
Press
contact
Katia Barcaroli
k.barcaroli@iris-pharma.com
or
StreetLab
Emmanuel
Gutman
emmanuel.gutman@institut-vision.org
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo